Adalimumab for refractory idiopathic scleritis in children

Clin Exp Rheumatol. 2022 Jul;40(7):1447-1448. doi: 10.55563/clinexprheumatol/8v3f7i. Epub 2022 Feb 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Humans
  • Scleritis* / diagnosis
  • Scleritis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Adalimumab